Pages
-
-
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
-
-
Surgical outcome and oncological survival of osteofibrous dysplasia-like and classic adamantinomas an international multicenter study of 318 cases
-
-
How does the skeletal oncology research group algorithm's prediction of 5-year survival in patients with chondrosarcoma perform on international validation?
-
-
The sacral chordoma margin
-
-
Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints
-
-
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
-
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
-
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 51, 2018)
-
-
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
-
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma A Multi-institutional Case Series
-
-
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
-
-
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
-
-
CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients
-
-
Fusion events lead to truncation of FOS in epithelioid hemangioma of bone
-
-
Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014)
-
-
Bone Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii113, 2014)
-
-
Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014)
-
-
CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients
-
-
Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis
-
-
Outcome of Advanced, Unresectable Conventional Central Chondrosarcoma
-
-
Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis
-
-
Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis
-
-
Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGF beta as Potential Targets
-
-
Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup
Pages